ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00
DPS 5Y CAGR	NaN%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANIP	$80.30	+2.27%	165.37K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANIP	$80.30	+2.3%	165.37K
3
4
5
6

ANIP

ANIP

Dividend Overview

Dividend Per Share - 5 Year History

Get ANI Pharmaceuticals Inc. Data in Excel

Get ANI Pharmaceuticals Inc. Data in Excel